|
 |
EmcytThis page contains recent news articles, when available, and an overview of Emcyt but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Emcyt (when available) Estramustine is an antineoplastic agent indicated in the palliative treatment of patients with metastatic and/or progressive carcinoma of the prostate. Estramustine is a combination of estradiol with nornitrogen mustard. The precise mechanism of action of estramustine is unknown. Unlike other alkylating agents, estramustine does not directly damage DNA. For the palliative treatment of patients with metastatic and/or progressive carcinoma of the prostate Mechanism Of Action: The precise mechanism of action of estramustine is unknown. News Articles on Estramustine New Oral Agent, Tasquinimod, May Have Activity in Prostate Cancer - Oct 26, 2009 Chemotherapy agents for patients with HRPC include: Taxotere® (docetaxel), Emcyt® (estramustine), Novantrone® (mitoxantrone), ixabepilone, ... Cancer Consultants Cytogen Corporation Provides QUADRAMET(R) Clinical Development … - Mar 17, 2005 ...sodium (Emcyt(R)) in hormone refractory prostate cancer patients. with high risk clinically localized prostate cancer. The. setting. ... RedOrbit Best of UAU Atlanta 2006. - Jul 1, 2006 ...progressive metastatic androgen-independent prostate cancer treated with the combination of docetaxel, estramustine (Emcyt), and thalidomide (Thalomid). ... Free with registration - Urology Times - AccessMyLibrary.com Rifampin (Systemic).(Drug overview) - Aug 1, 2006 Calan) -- Rifampin may decrease the effects of these medicines Estramustine (eg, EMCYT) or Estrogens (female hormones) or Oral contraceptives (birth ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Generic name product may also be available in the US - Jul 28, 2005 Calan) -- Rifampin may decrease the effects of these medicines Estramustine (eg, EMCYT) or Estrogens (female hormones) or Oral contraceptives (birth ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Oral agent shows efficacy as second-line PCa therapy.(Prostate Cancer) - Feb 1, 2007 Although several chemotherapy agents are used to treat hormone-refractory prostate cancer, including estramustine phosphate (Emcyt), ... Free with registration - Urology Times - AccessMyLibrary.com Triple therapy may be option in hormone-refractory PCa.(Prostate... - Aug 1, 2006 ...thalidomide (Thalomid), and estramustine phosphate sodium (Emcyt) demonstrated a 90% response rate, defined as a decline in PSA levels of at least 50%, ... Free with registration - Urology Times - AccessMyLibrary.com Rifampin, Isoniazid, and Pyrazinamide (Systemic).(Drug overview) - May 1, 2006 Norpace) or Estramustine (eg, Emcyt) or Fluconazole (eg, Diflucan) or Human immunodeficiency virus (HIV) protease inhibitors (medicines for the ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Brand Names/Synonyms: Emcyt is also known by the following brand names and/or synonymsEmcyt; Estracyt; Estramustin Sodium Phosphate; Estramustina [Inn-Spanish]; Estramustine; Estramustine Sodium Phosphate; Estramustine [Usan:Ban:Inn]; Estramustinum [Inn-Latin]; Leo 275 Drug Category: Emcyt is categorized under the following by the FDA: Antineoplastic Agents; Antineoplastic Agents; Radiation-Protective Agents; ATC:L01XX11 Dosage Forms: CAPSULE Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: (17-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl)bis(2-chloroethyl)aminomethanoate |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |